Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Hubei Minkang Pharmaceutical Ltd. | Financial_Report.xls |
| EX-32.1 - EXHIBIT 32.1 - Hubei Minkang Pharmaceutical Ltd. | v234656_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Hubei Minkang Pharmaceutical Ltd. | v234656_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Hubei Minkang Pharmaceutical Ltd. | v234656_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - Hubei Minkang Pharmaceutical Ltd. | v234656_ex32-2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Amendment #2)
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended June 30, 2011.
or
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934
|
For the transition period from to to
|
Commission File Number :
|
000-53231.
|
HUBEI MINKANG PHARMACEUTICAL LTD.
(Exact name of registrant as specified in its charter)
|
Nevada
|
26-24106855
|
|
(State or other jurisdiction of incorporation or
organization)
|
(I.R.S. Employer Identification No.)
|
|
2808 Cowan Circle
Las Vegas, NV
(Address of principal executive offices)
|
89107
(Zip Code)
|
|
866-446-1869
|
|
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
x Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
¨ Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
|
Non-accelerated filer
|
¨ (Do not check if a smaller reporting company)
|
Smaller reporting company
|
x
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
x Yes ¨ No
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
¨ Yes ¨ No
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 9,547,169 shares of common stock with a par value of $0.001 as of August 11, 2011.
EXPLANATORY NOTE
The sole purpose of this Amendment No. 2 to the Quarterly Report on Form 10-Q for the period ended June 30, 2011 is to furnish the correct Exhibit 101 to the Amendment No. 1 to this Quarterly Report, as required by Rule 405 of Regulation S-T.
No other changes have been made to the Amendment No. 1. This Amendment No. 2 does not reflect subsequent events occurring after the date of the original filing or modify or update in any way disclosures made in the original filing.
EXHIBIT INDEX
|
Exhibit
|
||
|
Number
|
Description of Document
|
|
|
31.1
|
Certificate pursuant to Rule 13a-14(a)
|
|
|
31.2
|
Certificate pursuant to Rule 13a-14(a)
|
|
|
32.1
|
Certificate pursuant to 18 U.S.C. §1350
|
|
|
32.2
|
Certificate pursuant to 18 U.S.C. §1350
|
|
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
11
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
HUBEI MINKANG PHARMACEUTICAL LTD.
(Registrant)
|
|
|
Date: September 13, 2011
|
By: /s/ Hsien Loong Wong
|
|
Hsien Loong Wong
|
|
|
President, CEO, CFO, Secretary, Treasurer and Director
(Principal Executive Officer and Principal Financial Officer)
|
12